ENTRY       D11872                      Drug
NAME        Serclutamab (USAN/INN)
FORMULA     C6438H9964N1710O2005S46
EXACT_MASS  144783.7442
MOL_WEIGHT  144873.2448
SEQUENCE    (Heavy chain)
            EVQLQESGPG LVKPSQTLSL TCTVSGYSIS RDFAWNWIRQ PPGKGLEWMG YISYNGNTRY
            QPSLKSRITI SRDTSKNQFF LKLNSVTAAD TATYYCVTAS RGFPYWGQGT LVTVSSASTK
            GPSVFPLAPS SKSTSGGTAA LGCLVKDYFP EPVTVSWNSG ALTSGVHTFP AVLQSSGLYS
            LSSVVTVPSS SLGTQTYICN VNHKPSNTKV DKKVEPKSCD KTHTCPPCPA PELLGGPCVF
            LFPPKPKDTL MISRTPEVTC VVVDVSHEDP EVKFNWYVDG VEVHNAKTKP REEQYNSTYR
            VVSVLTVLHQ DWLNGKEYKC KVSNKALPAP IEKTISKAKG QPREPQVYTL PPSREEMTKN
            QVSLTCLVKG FYPSDIAVEW ESNGQPENNY KTTPPVLDSD GSFFLYSKLT VDKSRWQQGN
            VFSCSVMHEA LHNHYTQKSL SLSPGK
            (Light chain)
            DIQMTQSPSS MSVSVGDRVT ITCHSSQDIN SNIGWLQQKP GKSFKGLIYH GTNLDDGVPS
            RFSGSGSGTD YTLTISSLQP EDFATYYCVQ YAQFPWTFGG GTKLEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide brige: H22-H96, H143-H199, H219-L214, H225-H'225, H228-H'228, H260-H320, H366-H424, H'22-H'96, H'143-H'199, H'219-L'214, H'260-H'320, H'366-H'424, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-epidermal growth factor receptor antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of advanced solid tumors
TARGET      EGFR [HSA:1956] [KO:K04361]
  PATHWAY   hsa04010(1956)  MAPK signaling pathway
            hsa04012(1956)  ErbB signaling pathway
            hsa05200(1956)  Pathways in cancer
BRITE       Target-based classification of drugs [BR:br08310]
             Protein kinases
              Receptor tyrosine kinases (RTK)
               EGFR family
                EGFR
                 D11872  Serclutamab (USAN/INN)
DBLINKS     CAS: 2140172-41-2
///
